Abstract TH168: Uncontrolled Hypertension is Associated With Increased Rates of Dementia: The EnligHTN Study
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.th168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Vivek Bhalla und 4 weiteren Autor:innen.
Themen: Demenz
Abstract (Originalsprache)
Introduction
Despite the availability of various treatment options, uncontrolled hypertension (uHTN) remains prevalent, significantly increasing risks of cardiorenal disease and mortality. uHTN is increasingly recognized as a risk factor for long-term cognitive outcomes. The 2025 AHA/ACC clinical practice guideline included revised recommendations, based largely on clinical trial data, upgrading the importance of achieving blood pressure (BP) control to prevent mild cognitive impairment (MCI) and dementia. Understanding the prognosis of patients with uHTN in real-world settings is vital for informing optimal management strategies. Hypothesis: This real-world evidence study investigated whether rates of incident MCI and dementia were higher in patients with uncontrolled (vs controlled) HTN.
Methods
Data from IQVIA Ambulatory EMR linked with IQVIA PharMetrics® Plus Closed Health Plan claims (US) were included. Between 2018 and 2023, patients with a hypertension (HTN) diagnosis whose first BP measurement while treated with ≥2 anti-hypertensive (anti-HTN) drugs for ≥30 days (index) was above BP target (≥130/80 mmHg) were considered uHTN and those below were considered controlled HTN (cHTN). Incidence (per 10,000 person-years) of MCI and dementia during follow-up was calculated. Unadjusted and multivariable Cox proportional hazards models (adjusted for baseline imbalances in patient characteristics) assessed differences in rates between the two groups.
Results
A total of 41,251 (uHTN=28,686) and 41,368 (uHTN=28,752) patients with a diagnosis of HTN treated with ≥2 anti-HTN medications were included in the MCI and dementia analyses, respectively. The average age at index was 59 years (standard deviation [SD] 11) and 57 years (SD 11) in patients with cHTN and uHTN, respectively. Follow-up time was ~ 2.5 years. The incidence rate (per 10,000 person-years) of MCI was 33.2 (95% confidence interval [CI] 27.4, 40.0) and 25.3 (95% CI 21.9, 29.1) in patients with cHTN and uHTN, respectively. The incidence rate of dementia was 32.6 (95% CI 26.8, 39.2) and 20.7 (95% CI 17.7, 24.2) in patients with cHTN and uHTN, respectively. This resulted in unadjusted hazard ratios (HR) for MCI and dementia of 0.76 (95% CI 0.60, 0.96) and 0.64 (95% CI 0.50, 0.81), respectively, in patients with uHTN (vs cHTN). However, after adjusting for differences in baseline characteristics (e.g., age, comorbidities, medication use), patients with uHTN had higher rates of MCI (HR: 3.89 [95% CI 2.59, 5.83]) and dementia (HR: 3.27 [95% CI 2.19, 4.89]), compared with patients with cHTN.
Conclusions
In conclusion, uHTN was associated with increased rates of MCI and dementia during follow-up, after adjusting for differences in baseline patient characteristics. Early identification and implementation of effective management strategies for uHTN may be crucial to improving long-term cognitive outcomes in these patients.
Zitieren
APA
Bhalla, V., Erhard, C., Norris, T., Coto, E., & McCormack, T. (2026). Abstract TH168: Uncontrolled Hypertension is Associated With Increased Rates of Dementia: The EnligHTN Study. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th168
Vancouver
Bhalla V, Erhard C, Norris T, Coto E, McCormack T. Abstract TH168: Uncontrolled Hypertension is Associated With Increased Rates of Dementia: The EnligHTN Study. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th168
BibTeX
@article{Bhalla2026,
author = {Bhalla, Vivek and Erhard, Clement and Norris, Tom and Coto, Esteban and McCormack, Terry},
title = {Abstract TH168: Uncontrolled Hypertension is Associated With Increased Rates of Dementia: The EnligHTN Study},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.th168}
}
EUVIMED